Yansong Lin
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib (NCT05007093) | Yansong Lin | 2020-12-01 |
Track Yansong Lin automatically
Every clearance here is in the API, with alerts when new ones post.